The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Inflammatory indexes neutrophils/lymphocytes, platelets/lymphocytes and red-cell distribution width (RDW) as prognostic biomarkers in advanced solitary fibrous tumors (SFT) treated with pazopanib: Correlative study of GEIS-32 trial.
 
Javier Martin Broto
Honoraria - Bayer; Eisai; Lilly; PharmaMar
Consulting or Advisory Role - Amgen; Bayer; GlaxoSmithKline; Novartis; PharmaMar
Speakers' Bureau - PharmaMar
Research Funding - Amgen (Inst); Bayer (Inst); Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Eisai; Eisai (Inst); FORMA Therapeutics (Inst); GlaxoSmithKline (Inst); Immix BioPharma (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Nektar (Inst); Novartis; Novartis (Inst); PharmaMar
Expert Testimony - Novartis; PharmaMar
Travel, Accommodations, Expenses - Pfizer; PharmaMar
 
Samuel Hidalgo
No Relationships to Disclose
 
David Silva Moura
Travel, Accommodations, Expenses - PharmaMar
 
Silvia Stacchiotti
Honoraria - GlaxoSmithKline; Lilly; Novartis; PharmaMar
Consulting or Advisory Role - Bavarian Nordic; Bayer; Daiichi Sankyo; Deciphera; Epizyme; GlaxoSmithKline; Lilly; MaxiVax; Novartis; PharmaMar
Research Funding - Advenchen Laboratories (Inst); Amgen (Inst); Bayer (Inst); Blueprint Medicines; Daiichi Sankyo (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); SpringWorks Therapeutics (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Antonio Lopez-Pousa
No Relationships to Disclose
 
Andrés Redondo
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
Research Funding - Eisai (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar
 
Antoine Italiano
No Relationships to Disclose
 
Antonio Gutierrez
No Relationships to Disclose
 
Giovanni Grignani
Honoraria - Bayer; Eisai; GlaxoSmithKline; GlaxoSmithKline; Lilly; Merck Serono; Novartis; Pfizer; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Eisai; PharmaMar
Speakers' Bureau - GlaxoSmithKline; GlaxoSmithKline
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar; tesaro
 
Nadia Hindi
Honoraria - PharmaMar
Research Funding - Adaptimmune (Inst); Amgen (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Daychii (Inst); Deciphera (Inst); Eisai (Inst); FORMA Therapeutics (Inst); GlaxoSmithKline (Inst); Immix BioPharma (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Jose Antonio Lopez-Guerrero
No Relationships to Disclose
 
Xavier Garcia del Muro
No Relationships to Disclose
 
Javier Martinez-Trufero
Consulting or Advisory Role - Eisai; PharmaMar; Sanofi
Research Funding - Blueprint Medicines (Inst); Lilly (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Amgen; Merck; PharmaMar; PharmaMar
 
Emanuela Palmerini
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Deciphera; EUSA Pharma; EUSA Pharma; Lilly
Research Funding - Daiichi Sankyo; PharmaMar (Inst)
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Lilly; Takeda
 
Ana Sebio
No Relationships to Disclose
 
Daniel Bernabeu
No Relationships to Disclose
 
Axel Le Cesne
Honoraria - Bayer; PharmaMar
 
Paolo Giovanni Casali
No Relationships to Disclose
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bayer; BMS; Deciphera; Ignyta; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; Pharmamar; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); DEciphera (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); OSE Pharma (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Josefina Cruz Jurado
Consulting or Advisory Role - Amgen; AstraZeneca; DAICHII; Eisai; GlaxoSmithKline; Lilly; Novartis; Pfizer; PharmaMar; Roche; Seagen
Speakers' Bureau - AstraZeneca; Eisai; Lilly; Novartis; Pfizer; PharmaMar; Roche
Travel, Accommodations, Expenses - Novartis; PharmaMar